Placental functional assessment using MRI: Mice today, humans tomorrow?;L'IRM fonctionnelle pour l'étude de la fonction placentaire: Aujourd'hui chez la souris, demain chez l'homme?

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 34, Issue 7 I, 2005, Pages 666-673

  Salomon, L J ^a,b   Siauve, N ^a,c   Taillieu, F ^a   Balvay, D ^a   Clement O ^a,c   Vayssettes, C ^a   Frija, G ^a,c   Ville, Y ^b   Cuenod C A ^a,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b CENTRE HOSPITALIER INTERCOMMUNAL   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Contrast media; Functional imaging; MRI; Perfusion; Permeability; Placenta

Indexed keywords

CONTRAST MEDIUM; GADOTERATE MEGLUMINE; TRACER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DIAGNOSTIC IMAGING; IMAGE ANALYSIS; MICROCIRCULATION; MORBIDITY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLACENTA FUNCTION; PLACENTA INSUFFICIENCY;

EID: 33244478516     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0368-2315(05)82899-6     Document Type: Article

References (55)

1. Gagnon R. Placental insufficiency and its consequences. Eur J Obstet Gynecol Reprod Biol 2003; 110 Suppl 1: 99-107.
2. Roberts JM, Lain KY. Recent Insights into the pathogenesis of pre-eclampsia. Placenta 2002; 23: 359-72.
3. Pijnenborg R, Anthony J, Davey DA, Rees A, Tiltman A, Vercruysse L, et al. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol 1991; 98: 648-55.
4. Zhou Y, Damsky CH, Chiu K, Roberts JM, Fisher SJ. Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J Clin Invest 1993; 91: 950-60.
5. Pijnenborg R, Robertson WB, Brosens I, Dixon G. Review article: trophoblast invasion and the establishment of haemochorial placentation in man and laboratory animals. Placenta 1981; 2: 71-91.
6. Jansson T, Powell TL. Placental nutrient transfer and fetal growth. Nutrition 2000; 16: 500-02.
7. Mihaly GW, Morgan DJ. Placental drug transfer: effects of gestational age and species. Pharmacol Ther 1983; 23: 253-66.
8. Polliotti BM, Holmes R, Cornish JD, Hulsey M, Keesling S, Schwartz D, et al. Long-term dual perfusion of isolated human placental lobules with improved oxygenation for infectious diseases research. Placenta 1996; 17: 57-68.
9. Papageorghiou AT, Yu CK, Nicolaides KH. The role of uterine artery Doppler in predicting adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 2004; 18: 383-96.
10. Gagnon R, Van den Hof M. The use of fetal Doppler in obstetrics. J Obstet Gynaecol Can 2003; 25: 601-14; quiz 615-6.
11. Nagayama M, Watanabe Y, Okumura A, Amoh Y, Nakashita S, Dodo Y. Fast MR imaging in obstetrics. Radiographics 2002; 22: 563-80; discussion 580-562.
12. Levine D, Barnes PD, Edelman RR. Obstetric MR imaging. Radiology 1999; 211: 609-17.
13. Zhu XP, Li KL, Kamaly-Asl ID, Checkley DR, Tessier JJ, Waterton JC, et al. Quantification of endothelial permeability, leakage space, and blood volume in brain tumors using combined T1 and T2* contrast-enhanced dynamic MR imaging. J Magn Reson Imaging 2000; 11: 575-85.
14. Vallee JP, Sostman HD, MacFall JR, Coleman RE. Quantification of myocardial perfusion with MRI and exogenous contrast agents. Cardiology 1997; 88: 90-105.
15. Brasch R, Turetschek K. MRI characterization of tumors and grading angiogenesis using macromolecular contrast media: status report. Eur J Radiol 2000; 34:148-55.
16. Pradel C, Siauve N, Bruneteau G, Clement O, De Bazelaire C, Froin F, et al. Reduced capillary perfusion and permeability in human tumour xenografts treated with the VEGF signaling inhibitor ZD4190: an in vivo assessment using dynamic MR imaging and macromolecular contrast media. Magn Reson Imaging 2003; 21: 845-51.
17. Eskey CJ, Koretsky AP, Domach MM, Jain RK. 2H-nuclear magnetic resonance imaging of tumor blood flow: spatial and temporal heterogeneity in a tissue-isolated mammary adenocarcinoma. Cancer Res 1992; 52: 6010-9.
18. Cuenod C, Leconte I, Siauve N, Resten A, Dromain C, Poulet B, et al. Early changes in liver perfusion caused by occult metastases in rats: detection with quantitative CT. Radiology 2001; 218: 556-61.
19. Low RN. MR imaging of the liver using gadolinium chelates. Magn Reson Imaging Clin N Am 2001; 9: 717-43.
20. Schaefer PW, Romero JM, Grant PE, Wu O, Sorensen AG, Koroshetz W, et al. Perfusion magnetic resonance imaging of acute ischemic stroke. Semin Roentgenol 2002; 37: 230-6.
21. Schalla S, Higgins CB, Saeed M. Contrast agents for cardiovascular magnetic resonance imaging. Current status and future directions. Drugs R D 2002; 3: 285-302.
22. Clement O, Pradel C, Siauve N, Frouin F, Bruneteau G, Kahn E, et al. Assessing perfusion and capillary permeability changes induced by a VEGF inhibitor in human tumor xenografts using macromolecular MR imaging contrast media. Acad Radiol 2002; 9 Suppl 2: S328-29.
23. Watzinger N, Maier R, Reiter U, Reiter G, Fuernau G, Wonisch M, et al. Clinical applications of cardiovascular magnetic resonance. Curr Pharm Des 2005; 11: 457-75.
24. Tailleu F, Salomon LJ, Siauve N, Cuenod C, Faye N, Balvay D, et al. Simultaneous placental and permeability assessment by dual echo contrast enhanced MRI in mice. Radiology 2005; sous presse.
25. Salomon LJ, Siauve N, Cuenod CA, Vayssettes C, Balvay D, Luciani A, et al. Placental perfusion assessment by functional MRI using contrast agent. A feasibility study in mice. Radiology 2004; In press.
26. Challier J. Échanges maternofoetaux. In: Sciences-Flammarion M, ed. Obstétrique. E. Papiernik. Paris, 1995; 19-31.
27. Adamson SL, Lu Y, Whiteley KJ, Holmyard D, Hemberger M, Pfarrer C, et al. Interactions between trophoblast cells and the maternal and fetal circulation in the mouse placenta. Dev Biol 2002; 250: 358-73.
28. Lawson RS. Application of mathematical methods in dynamic nuclear medicine studies. Phys Med Biol 1999; 44: 57-98.
29. Brown RF. Compartimental system analysis: state of the art. IEEE Trans Biomed Eng 1980; 27: 1-11.
30. De Bazelaire C, Siauve N, Frija G. Quantification en IRM de la microcirculation tumorale à l'aide d'agents de contraste diffusibles et macromoléculaires chez le rat. In : Laboratoire de Recherche en Imagerie. Inserm U494. Paris, 1999.
31. Pradel C, Siauve N, Frija G. Effets d'un traitement antiangiogé nique sur la microcirculation tumorale: mise en évidence par IRMf chez la souris à l'aide d'un agent de contraste macromoléculaire. In:Faculté de médecine Pitié-Salpétrière. Paris: Paris VI, 2000.
32. Bessoud B, Siauve N, Frija G. Étude des effets de deux modalité d'administration d'un agent antiangiogénique anti-VEGF sur la microcirculation tumorale en IRMf à l'aide d'un agent de contraste macromoléculaire. In : Laboratoire de Recherche en Imagerie. Inserm U 494. Paris, 2001.
33. Schroder HJ. Comparative aspects of placental exchange functions. Eur J Obstet Gynecol Reprod Biol 1995; 63: 81-90.
34. Evain-Brion. Le placenta humain: neuf mois d'une activité encore méconnue. Medecine Therapeutique/Pediatrie 1998; 1 : 509-16.
35. Zygmunt M, Herr F, Munstedt K, Lang U, Liang OD. Angiogenesis and vasculogenesis in pregnancy. Eur J Obstet Gynecol Reprod Biol 2003; 110 Suppl 1: 10-8.
36. Gowland PA, Francis ST, Duncan KR, Freeman AJ, Issa B, Moore RJ, et al. In vivo perfusion measurements in the human placenta using echo planar imaging at 0.5 T. Magn Reson Med 1998; 40: 467-73.
37. Cusick W, Salafia CM, Ernst L, Rodis JF, Campbell WA, Vintzileos AM. Low-dose aspirin therapy and placental pathology in women with poor prior pregnancy outcomes. Am J Reprod Immunol 1995; 34:141-7.
38. Tauber U, Weinmann HJ, Panzer M, Acksteiner B, Vollert B, Schulze PE. Whole-body autoradiographic studies in rats with gadolinium- diethylenetriaminepentaacetic acid, a new contrast agent for magnetic resonance imaging. Arzneimittelforschung 1986; 36: 1089-91.
39. Novak Z, Thurmond AS, Ross PL, Jones MK, Thornburg KL, Katzberg RW. Gadolinium-DTPA transplacental transfer and distribution in fetal tissue in rabbits. Invest Radiol 1993; 28: 828-30.
40. Okazaki O, Kurata T, Yoshioka N, Hakusui H. Pharmacokinetics and stability of caldiamide sodium in rats. Arzneimittelforschung 1996; 46: 79-83.
41. Olsen GD. Placental permeability for drugs of abuse and their metabolites. NIDA Res Monogr 1995; 154:152-62.
42. Garland M. Pharmacology of drug transfer across the placenta. Obstet Gynecol Clin North Am 1998; 25: 21-42.
43. Audus KL. Controlling drug delivery across the placenta. Eur J Pharm Sci 1999; 8:161-5.
44. Buniatova IM. Effect of generalized staphylococcal infection on permeability of placenta barrier and distribution of ristomycin sulphate in blood and organs of albino rats. Antibiotiki 1972; 17: 246-9.
45. Maidji E, Percivalle E, Gerna G, Fisher S, Pereira L. Transmission of human cytomegalovirus from infected uterine microvascular endothelial cells to differentiating/invasive placental cytotrophoblasts. Virology 2002; 304: 53-69.
46. Roberts CT, Sohlstrom A, Kind KL, Earl RA, Khong TY, Robinson JS, et al. Maternal food restriction reduces the exchange surface area and increases the barrier thickness of the placenta in the guinea-pig. Placenta 2001; 22: 177-85.
47. Barker G, Cunliffe N, Bardsley WG, D'Souza SW, Donnai P, Boyd RD. Fetal and maternal blood volumes in shed human placentae: discrepant results comparing morphometry to haemoglobin content. Placenta 1988; 9: 289-96.
48. Teasdale F. Idiopathic intrauterine growth retardation: histomorphometry of the human placenta. Placenta 1984; 5: 83-92.
49. Naganawa S, Koshikawa T, Nakamura T, Fukatsu H, Ishigaki T, Aoki I. High-resolution T1-weighted 3D real IR imaging of the temporal bone using triple-dose contrast material. Eur Radiol 2003.
50. Colletti PM, Sylvestre PB. Magnetic resonance imaging in pregnancy. Magn Reson Imaging Clin N Am 1994; 2:291-307.
51. Okada F, Sagami F, Tirone P, Morisetti A, Bussi S, Baguley JK. Reproductive and developmental toxicity study of gadobenate dimeglumine formulation (E7155) (1)-Fertility study in male rats by intravenous administration. J Toxicol Sci 1999; 24 Suppl. 1: 61-9.
52. Rofsky NM, Pizzarello DJ, Weinreb JC, Ambrosino MM, Rosenberg C. Effect on fetal mouse development of exposure to MR imaging and gadopentetate dimeglumine. J Magn Reson Imaging 1994; 4: 805-07.
53. Barzilai S, Stahl B, Merlob P. Gadolinium during pregnancy. Harefuah 1999; 137: 242-3.
54. Webb JA, Thomsen HS, Morcos SK. The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol 2005; 15: 1234-40.
55. Palacios Jaraquemada JM, Bruno C. Gadolinium-enhanced MR imaging in the differential diagnosis of placenta accreta and placenta percreta. Radiology 2000; 216: 610-1.